Novo Nordisk, the maker of the mega-popular diabetes and weight loss medications Ozempic and Wegovy, is set to report its first quarter earnings on May 2. Related Content The rise of Ozempic maker Novo Nordisk to one of the world's most valuable companies Ozempic maker Novo Nordisk's new weight loss pill could be 'best-in-class,' CEO says Wegovy and Ozempic: Are we ready for weight loss drugs? CC Share Subtitles Off English Share this Video Facebook Twitter Email Reddit Link view video Wegovy